Acute supplementation with the nitric oxide precursor l-arginine does not improve cardiovascular performance in patients with hypercholesterolemia
- 31 December 1995
- journal article
- clinical trial
- Published by Elsevier in Atherosclerosis
- Vol. 118 (2) , 223-231
- https://doi.org/10.1016/0021-9150(95)05608-4
Abstract
No abstract availableKeywords
This publication has 21 references indexed in Scilit:
- Non-invasive detection of endothelial dysfunction in children and adults at risk of atherosclerosisThe Lancet, 1992
- L-arginine improves endothelium-dependent vasodilation in hypercholesterolemic humans.Journal of Clinical Investigation, 1992
- Antiatherogenic effects of L-arginine in the hypercholesterolemic rabbit.Journal of Clinical Investigation, 1992
- Atherosclerosis or lipoprotein-induced endothelial dysfunction. Potential mechanisms underlying reduction in EDRF/nitric oxide activity.Circulation, 1992
- Correction of endothelial dysfunction in coronary microcirculation of hypercholesterolaemic patients by L-arginineThe Lancet, 1991
- Treatment of familial hypercholesterolaemia: a controlled trial of the effects of pravastatin or cholestyramine therapy on lipoprotein and apolipoprotein levelsJournal of Internal Medicine, 1990
- Impaired vasodilation of forearm resistance vessels in hypercholesterolemic humans.Journal of Clinical Investigation, 1990
- EFFECTS OF ENDOTHELIUM-DERIVED NITRIC OXIDE ON PERIPHERAL ARTERIOLAR TONE IN MANThe Lancet, 1989
- Endothelium‐dependent inhibition of platelet aggregationBritish Journal of Pharmacology, 1986
- Crucial role of endothelium in the vasodilator response to increased flow in vivo.Hypertension, 1986